Table 1.
Peptides significantly different phosphorylated upon GD1a treatment of OLGs (6 d in differentiation) as compared to vehicle treatment
| Condition | Peptides up | Peptides down |
|---|---|---|
| 0 vs 10 min | GPSM2_394_406 | |
| 0 vs 20 min | ANXA1_209_221 | CREB1_126_138 |
| BAD_112_124 | CDC2_154_169 | |
| CDN1A_139_151 | ||
| DESP_2842_2854 | ||
| EPB42_241_253 | ||
| FRAP_2443_2455 | ||
| KCC2G_278_289 | ||
| RS6_228_240 | ||
| SCN7A_898_910 | ||
| VASP_271_283 | ||
| 0 vs 16 h | KCNA_438_450 | ACM1_421_433 |
| RYR1_4317_4329 | ANDR_785_797 | |
| ATM_1972_1984 | ||
| CA2D1_494_506 | ||
| CDK7_163_175 | ||
| GYS2_1_13 | ||
| KCNA2_422_454 | ||
| NR4A1_344_356 | ||
| 20 min vs 16 h | ATM_1972_1984 | ACM1_421_433 |
| CFTR_730_742 | ACM1_444_456 | |
| CREB1_126_138 | ACM4_456_468 | |
| ACM5_494_506 | ||
| ANDR_785_797 | ||
| ANXA1_209_221 | ||
| BAD_112_124 | ||
| CDC2_154_169 | ||
| CDN1A_139_151 | ||
| CENPA_1_14 | ||
| ERBB2_679_691 | ||
| GPSM2_394_406 | ||
| GYS2_1–13 | ||
| KCNA2_442_454 | ||
| KCNA3_461_473 | ||
| NR4A1_344_356 |